Literature DB >> 12482492

Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography.

U S Justesen1, C Pedersen, N A Klitgaard.   

Abstract

A simple HPLC method that quantitates all six currently available protease inhibitors and the nelfinavir active metabolite M8 in one assay is presented. A 500-microliter plasma sample was treated by liquid-liquid extraction with a mixture of heptane and ethyl acetate. After evaporation, the residue was redissolved in sodium dihydrogenphosphate and acetonitrile and washed twice with heptane. Chromatography was performed with an analytical C(18) column. Ultraviolet detection at 210 and 239 nm was used. The present method is associated with high accuracy and low imprecision in the concentration range of 25-5000 ng/ml of all six protease inhibitors and M8. This makes it suitable for monitoring purposes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482492     DOI: 10.1016/s1570-0232(02)00728-6

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues.

Authors:  Jiangeng Huang; Nagsen Gautam; Sai Praneeth R Bathena; Upal Roy; JoEllyn McMillan; Howard E Gendelman; Yazen Alnouti
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-07-01       Impact factor: 3.205

2.  HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study.

Authors:  Sophie Perrin; Jonathan Cremer; Olivia Faucher; Jacques Reynes; Pierre Dellamonica; Joëlle Micallef; Caroline Solas; Bruno Lacarelle; Charlotte Stretti; Elise Kaspi; Andrée Robaglia-Schlupp; Corinne Nicolino-Brunet; Corine Nicolino-Brunet Catherine Tamalet; Catherine Tamalet; Nicolas Lévy; Isabelle Poizot-Martin; Pierre Cau; Patrice Roll
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.